SJVIX | VIVIX | SJVIX / VIVIX | |
Total Expense Ratio | 0.75 | 0.04 | 1,875% |
Annual Report Gross Expense Ratio | 0.99 | 0.04 | 2,475% |
Fund Existence | 4 years | 27 years | - |
Gain YTD | 6.532 | 6.215 | 105% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 5000000 | 2% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 93.3M | 189B | 0% |
Annual Yield % from dividends | 1.35 | 2.19 | 61% |
Returns for 1 year | 10.62 | 12.05 | 88% |
Returns for 3 years | 47.76 | 35.17 | 136% |
Returns for 5 years | N/A | 80.14 | - |
Returns for 10 years | N/A | 115.68 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSERX | 9.47 | 0.10 | +1.07% |
MassMutual Small Cap Growth Eq R4 | |||
PMVEX | 25.84 | 0.18 | +0.70% |
PGIM Quant Solutions Mid-Cap Val R2 | |||
SBHIX | 23.25 | 0.11 | +0.48% |
Saratoga Health & Biotechnology I | |||
HFQSX | 6.79 | 0.02 | +0.30% |
Janus Henderson Global Equity Income S | |||
HHDVX | 36.13 | 0.09 | +0.25% |
Hamlin High Dividend Equity Inv |